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Introduction!

Thirty-two female ovariectomized Wistar rats
were obtained and randomly placed in Control,
Zolendronate (Zol), Sleep Deprived (SD), and
Sleep Deprived with Zolendronate (SDZ) groups.
Prior to experimental protocol the rats were
injected with either saline or Zolendronate (Table
1) and then given a one-week adaption period.
Starting at 14:00 each day all rats were placed in
their respected tanks (Table 1) where the SD and
SDZ groups would undergo sleep deprivation and
the Control and Zol groups would socialize. The
SD and SDZ groups were subjected to one of
three random sleep cycles (Table 2) each night
for five weeks to stimulate irregular sleep cycles
experienced by many post-menopausal women.
During the scheduled time the SD and SDZ
groups were being sleep deprived, the Control
and Zol groups were able to socialize and sleep
freely in the control tank.
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# of Rats

Injection

Sleep Deprived

Two Multiple Modified Platform (MMP) tanks, housing
each the sleep deprived (SD) or sleep deprived and
Zoledronate (SDZ) groups, were constructed according to
the dimensions found in Figure 1. A third tank, lacking
platforms and surrounding water, was used to house rats in
the control (Con) and Zoledronate (Zol) groups.

MMPM Tank

Control

5

0.45mL 0.9% saline

No

1 (control)

Zol

9

50ug/kg Zolendronate

No

1 (control)

SD

9

0.45mL 0.9% saline

Yes

2

SDZ

9

50ug/kg Zolendronate

Yes

3

Table 1: Experimental Groups and Treatments.
Sleep Cycle

Time Awake
(hours)

Time Allowed for
Sleep (hours)

Start Time

End Time

SC1

19

5

14:00

9:00

SC2

18

6

14:00

8:00

SC3

17

7

14:00

7:00

Figure 1: Multiple Modified Platform Tank Design.
TNF-α plasma concentrations were determined by
enzyme-linked immunosorbent assay (ELISA). Bone
strength, area gradient and area were determined via a
three point bending test.

Table 2: Variable Sleep Cycles..

Results!
All data were treated by Analysis of Variance (ANOVA). Significance was accepted at p<.01. A Newman-Keuls post hoc
test was employed to identify the significantly different group.

3-Point Bending Test

TNF-α Concentration!

A 3-point bending task was performed on each of the
animals’ left femurs. The data is displayed In Figure 2.
These data show no significant differences in bone strength
among the groups.

An ELISA was performed to determine serum
concentrations of TNF-α (pg/mL). The data is displayed in
Figure 3. The Zolendronate group is the only group of
significance.

Figure 2: Average Bone Strength per Experimental Group.

Figure 3: Average TNF-a Concentration per Experimental.
Group

Average Bone Strength

TNF-a Concentration Values
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Novartis Institute for Biomedical Research (Basel,
Switzerland) for providing Zometa (Zoledronate) for the
study. We also thank Ken D. Sumida and Milton
Greenberg for their assistance and training, and Ashley
Whelpley for reagents and laboratory assistance. !
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!Significant changes in overall bone strength
were not found as a result of sleep deprivation or
Zolendronate injection, over the course of this
five-week study. The lack of significant changes
may be attributed to the short time frame of the
study. While five weeks has proven to be
sufficient time to induce chronic sleep deprivation
and to allow Zolendronate to effect bone
remodeling it was not a long enough time frame
for mechanical testing to show the differences in
bone metabolism and architecture.
There was a significant difference in the
serum concentrations of TNF-α among the
experimental groups. TNF-α levels were
significantly higher in the Zol group than both the
control and SD, and SDZ groups (p<0.01). The
high cytokine concentration in the Zol group may
be due to the fact that Zolendronate has been
shown to induce a transient fever in humans for
twenty-one days after injection. Therefore, it may
be possible that the measured cytokine level for
the Zol group may represent residual amounts of
the TNF-α present after the initial immune
response to the drug.
While it was expected that the SD and SDZ
groups would have elevated TNF-α
concentrations due to sleep deprivation, the TNFα concentrations of the SD and SDZ were
comparable to those of the control group. This
may be attributable to a possible exhaustion of
the animals’ immune systems. These findings
warrant further research measuring the changes
in cytokine concentration throughout a longer
sleep deprivation protocol to determine the
fluctuations of TNFα due to sleep deprivation and
Zolendronate and their effect on mechanical
difference in bone strength.
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Methods
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After undergoing the designated amount of sleep
deprivation/socialization all rats were placed back into their
individual cages and allowed to sleep for the allotted amount
of time based off a random number generator. Food and
water were available ad libitum for all groups during the
entire protocol.

Newtons (N)

Osteoporosis is a very common progressive
skeletal disease in which the microarchitecture of
bone tissue is slowly deteriorated causing a
decrease in bone mineral density (BMD) and an
increase in bone fragility. The cessation of
estrogen signaling after menopause causes an
imbalance between the osteoblasts which form
bone, and osteoclasts, which degrade bone.
Post-menopausal osteoporosis affects one in four
women in which about one third of those women
will experience a fracture due to the disease in
their lifetime.
Chronic sleep deprivation (receiving less than
six and a half hours of sleep a night) has been
found to exacerbate osteoporosis. Through the
production of an inflammatory response caused
by chronic sleep deprivation, pro-inflammatory
cytokines such as tumor necrosis factor alpha
(TNF-α) and interleukin one (IL-1) increase
osteoclastic activity, thus increasing bone
degradation and decreasing BMD. A preventative
drug known as Zolendronate, a bisphosphonate,
is used to decrease osteoclastic activity.
This study evaluates the concentration of a
cytokine, tumor necrosis factor alpha (TNF-α),
and the effects of Zolendronate on the relative
bone strength of female, ovariectomized (OVX)
Wistar rats subjected to a five-week sleep
deprivation protocol.
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Control

Zol

SD

SDZ

Control

Zol

*Significance determined p<0.01.

SD

SDZ
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